In this article, we will take a look at the 12 stocks that will double in 2025.
Mutual Advisors LLC bought a new position in ImmunityBio, Inc. (NASDAQ:IBRX – Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback